Tag: kamp

CMPI: Value of Prescription Drugs Is Underestimated

Amarin Federal Court Decision: FDA Off-Label Marketing Rules Violate the First Amendment By John Kamp

House Approves 21st Century Cures Act, Bill Now Heads to the Senate

Author of “Pharmaphobia” Says Conflict-of-interest Regulations Are Slowing Medical Progress

House Energy and Commerce Committee Wholeheartedly Approves 21st Century Cures Act

FDA Plans for Off-label Communication Draft Guidance, Meeting

PhRMA Authors Call for FDA to Establish Off-label Communication Safe Harbor

Coalition to Sponsor Medical Marketing Pitch Webinar

DAA Expands Ad Privacy Controls to Mobile Marketplace